Sort
10,829 grants matching “car t”
Catch and Release Immunotoxins: CAR-Bombs for Cancer
$363,056Joseph P Balthasar · State University Of New York At Buffalo · R01 · FY2020 · CA
Pathways of PAH activation in human lung cells
$362,450Trevor M. Penning · University Of Pennsylvania · R01 · FY2011 · ES
Targeted Nanomedicines with Synergistic Chemotherapeutics to Enhance Immunotherapy of Metastatic Colorectal Cancer
$362,362Wenbin Lin · University Of Chicago · R01 · FY2022 · CA
Transcriptional Coactivators in Liver Function
$362,340Janardan K. Reddy · Northwestern University At Chicago · R01 · FY2010 · DK
Protective Role of Nonclassical Monocytes in Immunotherapies for Solid Cancers
$362,294Catherine C Hedrick · La Jolla Institute For Immunology · U01 · FY2019 · CA
MDA-7/IL-24: Therapy of Prostate Cancer
$362,273Paul B Fisher · Columbia University Health Sciences · P01 · FY2007 · CA
Crosstalk between butyrophilins and gamma delta T cells in human cancer
$362,250Jose R Conejo-Garcia · Duke University · R01 · FY2025 · CA
Crosstalk between butyrophilins and gamma delta T cells in human cancer
$362,250Jose R Conejo-Garcia · Duke University · R01 · FY2024 · CA
Molecular and Dynamic Insights into the Function of GPCRs Involved in Drug Abuse
$361,985Marta Filizola · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · DA
IGF::OT::IGF VASCULAR INTERVENTIONS/INNOVATIONS AND THERAPEUTIC ADVANCES (VITA): CAR PEPTIDE THERAPEUTIC ADJUVANT FOR PAH TARGETED THERAPY
$361,958David Mann · Vascular Biosciences · N01 · FY2014 · HL
Does the inhibition of key xenobiotic-metabolizing CYPs cause obesity?
$361,775William S Baldwin · Clemson University · R15 · FY2016 · ES
ROLE OF THE G-CSF RECEPTOR IN PROGENITOR MOBILIZATION
$361,760Daniel C Link · Washington University · R01 · FY2013 · HL
Engager T cell: A Simple Solution for Off-the-shelf T Cell Therapy for Cancer
$361,635Gongbo Li · Immunebro Therapeutics Inc. · R43 · FY2024 · CA
Project 2: CAR-T cell therapy for T cell lymphoma
$361,547Malcolm K Brenner · Baylor College Of Medicine · P50 · FY2023 · CA
Intracerebrally delivered EGFRvIII-targeted CARs for brain tumors
$361,290John H Sampson · Duke University · P50 · FY2017 · CA
Understanding Real-Life Falls in Amputees using Mobile Phone Technology
$361,215Arun Jayaraman · Rehabilitation Institute Of Chicago D/B/A Shirley Ryan Abilitylab · R01 · FY2014 · EB
P38 MAPK is a molecular switch that controls the acquired resistance in adoptive cell therapy
$361,117Yong Lu · Methodist Hospital Research Institute · R37 · FY2023 · CA
Catch and Release Immunotoxins: CAR-Bombs for Cancer
$360,914Joseph P Balthasar · State University Of New York At Buffalo · R01 · FY2018 · CA
Tailored Adaptive Mobile Messaging to Reduce Problem Drinking
$360,801Frederick John Muench · Partnership To End Addiction · R01 · FY2020 · AA
Generating rapid antitumor immunity with lymphocyte-reprogramming nanocarriers
$360,766Matthias Stephan · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA
Generating rapid antitumor immunity with lymphocyte-reprogramming nanocarriers
$360,766Matthias Stephan · Fred Hutchinson Cancer Research Center · R01 · FY2020 · CA
A LEICA TCS SP CONFOCAL MICROSCOPE FOR WHITNEY LAB
$360,636University Of Florida · S10 · FY2000 · RR
Design and optimization of TCR-T therapeutics by an advanced T cell receptor-antigen binding prediction platform
$360,442Tao Wang · Nightstar Biotechnologies, Inc · R41 · FY2025 · CA
Naturalistic Assessment of the Driving ability of Cognitively Impaired Elders
$360,310Brian Richard Ott · Rhode Island Hospital · R01 · FY2010 · AG
PS11-1114, Community Approaches to Reducing STDs (CARS)
$360,174Danny Avula · Virginia State Dept Of Health · U22 · FY2011 · PS